Nurse Practitioner Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Brenda Barker

Nurse Practitioner, Family Casper, WY Nurse Practitioner

NPI 1710424940 CMS profile 10618944

111 S Jefferson St Ste 105, Casper, WY 82601

Open in the dashboard

General payments

$501

18 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Brenda Barker of Casper, WY is reported in the CMS Open Payments database as having received $501 across 18 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 58th percentile of Nurse Practitioner, Family profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $167 8
2024 General $133 4
2023 General $187 5
2021 General $15 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Brenda Barker
  • Nurse Practitioner, Family median
  • Middle half of Nurse Practitioner, Family
  • National median

In program year 2025, general payments to Brenda Barker were reported at $167. Among 107,232 Nurse Practitioner, Family profiles paid that year, the median was $168 and the middle half received between $53 and $521.

Show as a table
Year Brenda Barker Nurse Practitioner, Family median Middle half National median
2019 $0 $39 $18–$91 $163
2020 $0 $32 $17–$76 $114
2021 $15 $124 $35–$379 $132
2022 $0 $141 $44–$430 $149
2023 $187 $154 $49–$476 $160
2024 $133 $165 $51–$504 $164
2025 $167 $168 $53–$521 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Boston Scientific Corporation $430 15 payments
  2. AbbVie, Inc. $56 2 payments
  3. Otsuka America Pharmaceutical, Inc. $15 1 payment

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $501 18 payments
Products named General payments · program years 2021–2025
  1. WaveWriter Alpha Prime 16 $216 6 payments
  2. Patient Trial Kit $80 2 payments
  3. UBRELVY $56 2 payments
  4. General - Pain Management $55 4 payments
  5. Vercise $36 1 payment
  6. General - Therapies $15 1 payment
  7. ABILIFY MAINTENA $15 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 62 drugs

Part D claims

4,218

Median for Nurse Practitioner: 389

Drug cost

$170,893

Median for Nurse Practitioner: $21,885

Branded share of claims

30.3%

Median for Nurse Practitioner: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Xtampza Er Oxycodone Myristate Brand 57 $29,635
Oxycontin Oxycodone Hcl Brand 42 $17,264
Linzess Linaclotide Brand 27 $14,430
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 319 $12,756
Movantik Naloxegol Oxalate Brand 28 $11,194
Buprenorphine Generic 24 $9,558
Morphine Sulfate Er Morphine Sulfate Brand 352 $8,008
Oxycodone Hcl Generic 428 $7,423
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 222 $6,443
Hydromorphone Hcl Generic 162 $5,031

The 10 drugs with the highest cost, of 62 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 229,976 Part D prescribers listed as Nurse Practitioner; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 11 billing codes

Paid by Medicare

$97,756

Medicare's payments for the services billed

Medicare patients

123

Average age 65

Services billed

2,198

85 women, 38 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 63%
Arthritis 59%
Depression 45%
COPD 37%
Diabetes 28%
Ischemic heart disease 23%
Heart failure 16%
Chronic kidney disease 14%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

18 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Nurse Practitioner, Family in Wyoming

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record